We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App





BD Demonstrates Latest Medtech Innovations at MEDLAB Middle East 2021

By LabMedica International staff writers
Posted on 24 Jun 2021
Print article
Image: BD Demonstrates Latest Medtech Innovations at MEDLAB Middle East 2021 (Photo courtesy of Becton, Dickinson and Company)
Image: BD Demonstrates Latest Medtech Innovations at MEDLAB Middle East 2021 (Photo courtesy of Becton, Dickinson and Company)
Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) demonstrated its latest Medtech innovations at Medlab Middle East 2021 focusing on infection prevention and control, integrated diagnostics, and lab automation.

At this year’s Medlab Middle East, the company showcased its rapid diagnostic testing solutions to enable caregivers perform high number of tests in a short duration of time; advanced informatics and integrated diagnostics to enhance testing, automate workflows and help expedite decision-making; cutting-edge solutions for microbiology testing to facilitate rapid implementation of infection prevention and control measures; as well as microbiology automation amongst others. Experts from the BD team were also present at the company’s booth to host various in-depth sessions, share best practices, and demonstrate an array of innovative solutions to tackle the region’s ongoing healthcare challenges.

“Last year, the world was exposed to undesirable medical extremities,” said Maher Elhassan, Vice President & General Manager, BD Middle East, North Africa & Turkey. “Now is the time when communities in the region and throughout the world need our continued support and expertise to be able to fight all adversaries and recover. As part of our mission to advance the world of health, BD is determined to leave no stone unturned in our quest to impact people’s lives. Our participation at Medlab Middle East reiterates the company’s efforts to support the region’s healthcare sector with our latest innovations that deliver on patient care, safety, diagnostic accuracy, automation and more.”

Related Links:
Becton, Dickinson and Company

Gold Supplier
SARS-COV-2 PLUS UK Real Time PCR kit
SARS-COV-2 PLUS UK REALTIME PCR KIT
New
3-DIFF Hematology Analyzer
MYTHIC 18
New
Molecular Diagnostic System
FlashDetect Flash48
New
Chemiluminescence Analyzer
DZ-Lite 3000 Plus

Print article

Channels

Industry

view channel
Image: QIAGEN has acquired a majority stake in enzymes provider BLIRT S.A. (Photo courtesy of QIAGEN)

Qiagen Acquires Enzymes Provider Blirt to Strengthen Sample Technologies Business

QIAGEN N.V. (Venlo, Netherlands) has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A. (Gdansk, Poland), a manufacturer of recombinant enzymes for the life science industry.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.